𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transferrin Receptor Expression as a Marker of Immature Cycling Thymocytes in the Mouse

✍ Scribed by Pieter Brekelmans; Peter van Soest; Jane Voerman; Peter Paul Platenburg; Pieter J.M. Leenen; Willem van Ewijk


Book ID
112239155
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
318 KB
Volume
159
Category
Article
ISSN
0008-8749

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Expression of the human transferrin rece
✍ Marja-Liisa Lindholm; Lars-Axel Lindberg; Pekka Vilja; Veli-Matti Puolakka; Stig πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 662 KB

The expression of a cell proliferation marker, the human transferrin receptor, was studied in ten human gastrointestinal tumors prior to and after implantation under the renal capsule in the mouse (1-6 days). These data were compared to the increase in tumor size in situ, and to the infiltration of

Inhibition of heme synthesis decreases t
✍ A. Hradilek; O. Fuchs; J. Neuwirt πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 728 KB

The coordination of transferrin receptor (TfR) expression and heme synthesis was investigated in mouse erythroleukemia (MEL) cells of line 707 treated with heme synthesis inhibitors or in a variant line Fw genetically deficient in heme synthesis. Cells of line 707 were induced for differentiation b

Serum transferrin receptor as a marker o
✍ Tancabelic, Jakica; Sheth, Sujit; Paik, Myunghee; Piomelli, Sergio πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 52 KB πŸ‘ 1 views

In the management of patients requiring chronic transfusion, various parameters may be used to evaluate the degree of erythroid marrow suppression. The aim of our study was to assess which of these parameters provide the most useful assessment of erythropoiesis. We studied 27 chronically transfused

Engineering and expression of a chimeric
✍ Ruben J. Boado; Yun Zhang; Yuntao Wang; William M. Pardridge πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 286 KB πŸ‘ 2 views

## Abstract Protein therapeutics may be delivered across the blood–brain barrier (BBB) by genetic fusion to a BBB molecular Trojan horse. The latter is an endogenous peptide or a peptidomimetic monoclonal antibody (MAb) against a BBB receptor, such as the insulin receptor or the transferrin recepto